Compare Acadia Healthcare Company Inc (ACHC) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Acadia Healthcare Company Inc vs Prospect Capital Corporation — how do they compare? Acadia Healthcare Company Inc trades at $30.78 (market cap $2.94B), while Prospect Capital Corporation trades at $2.2 (market cap $1.10B). The key difference: Acadia Healthcare Company Inc is far larger — about 2.7× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 22.73% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | PSEC | |
|---|---|---|
Market Cap | $2.94B | $1.10B |
Sector | Health | Financials |
52-Week High | $31.92 | $3.47 |
52-Week Low | $11.68 | $2.15 |
Enterprise Value | $5.45B | — |
Dividend Yield | — | 22.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Prospect Capital Corporation (PSEC) trades at $2.20, down 1.79% recently, with a bearish technical outlook. The stock shows mixed fundamentals with a low P/B ratio of 0.37 but concerning negative revenue and net income margins. Recent earnings have consistently beaten expectations, with Q1 2026 EPS of $0.16 exceeding the $0.1109 forecast. The company maintains regular dividend payments, recently completing a $328 million portfolio sale that generated a 4.8x return on investment.
PSEC presents a high-risk opportunity with its deep discount to NAV and 18%+ yield attracting income investors, but fundamental deterioration and analyst skepticism pose significant challenges. The bearish technical signals and negative cash flow trends suggest caution, while the company's shift toward first-lien lending may improve portfolio quality over time. Investment suitability depends on risk tolerance for BDC volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
